British Journal of Cancer, 2025
Serum multiomics prediction of prognosis and adverse reactions to concurrent chemoradiotherapy in patients with esophageal cancer

Wu W., Huang H., Zhu G. et al.

Journal of Proteome Research, 2025
Discovering Biomarkers for Asymptomatic Tuberculosis via Olink Proteomics and Machine Learning

Sun Q., Li S., Ren W. et al.

Allergy, 2025
Dupilumab in Children Under 6 Years With Moderate‐to‐Severe Atopic Dermatitis: A 16‐Week Real‐World Prospective Study on Efficacy, Safety, and Local‐Systemic Immune Responses

Zhang Y., Pi J., Wang L. et al.

Open Forum Infectious Diseases, 2025
Two or three? Clinical and proteomic perspectives on dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide as initial HIV treatment

Díaz-García C., Serrano-Villar S., de Morales A. et al.

Medicine, 2025
Gut microbiota influences lung cancer risk through circulating cytokines—Insights from a Mendelian randomization study

Shen W., Hou R., Zhang J. et al.

The Journal of Clinical Endocrinology & Metabolism, 2025
Association of urinary copper and gestational diabetes mellitus: role of epigenome-wide DNA methylation and proteomics

Li Y., Zhang S., Lai Y. et al.

Brain, 2025
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers

Karlsson L., Janelidze S., Barthélemy N. et al.

BMC Medicine, 2025
Efficacy, safety, and exploratory biomarker analysis of envafolimab plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: a prospective, single-arm, phase II trial

Zhao X., Zhang J., Qiu L. et al.

BMC Nephrology, 2025
Association of Osteopontin and selective glomerular hypofiltration syndrome with hospitalization for kidney failure in acute heart failure patients

Ohlsson M., Nilsson C., Molvin J. et al.

Current Medicinal Chemistry, 2025
Mediating Effects of Plasma Metabolites in Inflammatory Protein-Lymphoma Causality: A Mendelian Randomization Study

Ji Y., Gao X., Liu L. et al.

Multiple Sclerosis and Related Disorders, 2025
Proteomics confirms immune stabilizing effects of narrowband UVB treatment in patients with clinically isolated syndrome and multiple sclerosis

Hart P., Emig C., Obeidat A. et al.

Cell Genomics, 2025
Multi-omic underpinnings of heterogeneous aging across multiple organ systems

Xiong J., Zhu X., Guo Y. et al.

Journal of Inflammation Research, 2025
Clinical Features, Treatment Effectiveness and Long-Term Outcomes in Children with Moderate-to-Severe Generalized Pustular Psoriasis: A Retrospective Cohort Study

Cao Z., Peng B., Li Z. et al.

GeroScience, 2025
Immune cells and inflammatory proteins are differentially associated with subsequent DNA methylation biological aging measures in the Framingham Heart Study Offspring Cohort

Rotti L., Murabito J., Chen J. et al.

Frontiers in Immunology, 2025
Integrative genetic and multi-omics analysis reveals the interleukin-6 receptor’s role in recurrent spontaneous abortion

Ma W., Gu Z., Lin Q. et al.

Nucleic Acids Research, 2025
ProteoNexus: an integrative database to characterize genetic architecture, estimate mediation effects, and construct and evaluate prediction models of the plasma proteome

Shao K., Luo Z., Huang P. et al.

Circulation: Heart Failure, 2025
Plasma Proteome Analysis Identifies Vascular Endothelial Growth Factor Receptor 1 as a Prognostic Biomarker in Cardiogenic Shock

Jung C., Lang A., Duse D. et al.

Open Heart, 2025
Association between circulating biomarkers and atrial fibrillation burden in patients with paroxysmal atrial fibrillation: a subanalysis of the RACE V study

Frausing M., Rienstra M., Kronborg M. et al.

Blood Advances, 2025
Population-scale Analysis Reveals Germline Loss of SERPING1 (C1-Inhibitor) is a Polyphenotypic Thrombotic Disorder

Rodriguez Espada A., Haj A., Jurgens S. et al.

Journal of Ophthalmology, 2025
Genetically Prioritized Plasma Proteins as Candidate Therapeutic Targets for Dry Age‐Related Macular Degeneration

Hou J., Guo J., Shen W. et al.